Blog: What is the Inflation Reduction Act (IRA) and what are the effects?
Inflation Reduction Act (IRA) medicine pricing rules are reshaping therapy development and financing, with ripple effects for patient access. This highlights episode revisits the pill penalty, the Medicare Part D redesign, and how those shifts can influence investment and formularies.
In our recent episode of the Vital Health Podcast, host Duane Schulthess speaks with five guests on the Inflation Reduction Act (IRA) and its ripple effects across medicine development, Medicare, and patient access:
– Donna Cryer, Founder at Global Liver Institute
– Barbara McAneny, CEO at New Mexico Cancer Center- New Mexico Oncology Hematology Consultants, LTD
– Rafa Fonseca, Chief Innovation Officer and Professor of Medicine at Mayo Clinic in Arizona
– Steve Potts, Chair, Drug Development Council at ICAN, International Cancer Advocacy Network
– Kirsten Axelsen, Fellow at The Aspen Institute